Solomon Moshkevich is PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc.. Currently has a direct ownership of 126,450 shares of NTRA, which is worth approximately $25.8 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 115 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
4.89% 3M change
8.08% 12M change
Total Value Held $25.8 Million

Solomon Moshkevich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2025
SELL
Bona fide gift
-
115 Reduced 0.09%
126,450 Common Stock
Dec 12 2025
SELL
Bona fide gift
-
180 Reduced 0.17%
108,881 Common Stock
Dec 12 2025
SELL
Open market or private sale
$1,082,725 $230.76 p/Share
4,692 Reduced 3.98%
113,065 Common Stock
Dec 12 2025
BUY
Exercise of conversion of derivative security
$214,585 $9.59 p/Share
22,376 Added 15.02%
126,565 Common Stock
Dec 01 2025
SELL
Open market or private sale
$714,570 $238.19 p/Share
3,000 Reduced 2.68%
109,061 Common Stock
Nov 03 2025
SELL
Open market or private sale
$596,880 $198.96 p/Share
3,000 Reduced 2.61%
112,061 Common Stock
Oct 28 2025
SELL
Open market or private sale
$229,369 $191.46 p/Share
1,198 Reduced 1.03%
115,061 Common Stock
Oct 27 2025
SELL
Open market or private sale
$193,858 $192.32 p/Share
1,008 Reduced 0.86%
116,259 Common Stock
Oct 21 2025
SELL
Open market or private sale
$54,881 $187.95 p/Share
292 Reduced 0.25%
117,267 Common Stock
Oct 01 2025
SELL
Open market or private sale
$479,580 $159.86 p/Share
3,000 Reduced 2.49%
117,559 Common Stock
Sep 15 2025
SELL
Bona fide gift
-
300 Reduced 0.25%
120,559 Common Stock
Sep 02 2025
SELL
Open market or private sale
$499,800 $166.6 p/Share
3,000 Reduced 2.42%
120,859 Common Stock
Aug 14 2025
SELL
Open market or private sale
$136,010 $155.44 p/Share
875 Reduced 0.7%
123,859 Common Stock
Aug 12 2025
BUY
Grant, award, or other acquisition
-
1,675 Added 1.33%
124,734 Common Stock
Aug 01 2025
SELL
Open market or private sale
$399,840 $133.28 p/Share
3,000 Reduced 2.38%
123,059 Common Stock
Jul 28 2025
SELL
Open market or private sale
$308,420 $139.81 p/Share
2,206 Reduced 1.72%
126,059 Common Stock
Jul 21 2025
SELL
Open market or private sale
$40,533 $139.29 p/Share
291 Reduced 0.23%
128,265 Common Stock
Jul 01 2025
SELL
Open market or private sale
$498,689 $166.23 p/Share
3,000 Reduced 2.25%
130,205 Common Stock
Jun 02 2025
SELL
Open market or private sale
$473,250 $157.75 p/Share
3,000 Reduced 2.2%
133,205 Common Stock
May 27 2025
SELL
Open market or private sale
$258,645 $156.85 p/Share
1,649 Reduced 1.27%
128,556 Common Stock
May 01 2025
SELL
Open market or private sale
$451,200 $150.4 p/Share
3,000 Reduced 2.16%
136,205 Common Stock
Apr 28 2025
SELL
Bona fide gift
-
75 Reduced 0.05%
139,205 Common Stock
Apr 28 2025
SELL
Open market or private sale
$335,709 $152.18 p/Share
2,206 Reduced 1.56%
139,280 Common Stock
Apr 21 2025
SELL
Open market or private sale
$43,275 $146.2 p/Share
296 Reduced 0.21%
141,486 Common Stock
Apr 01 2025
SELL
Open market or private sale
$422,370 $140.79 p/Share
3,000 Reduced 2.07%
141,782 Common Stock
SM

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS
Austin, TX

Track Institutional and Insider Activities on NTRA

Follow Natera, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTRA shares.

Notify only if

Insider Trading

Get notified when an Natera, Inc. insider buys or sells NTRA shares.

Notify only if

News

Receive news related to Natera, Inc.

Track Activities on NTRA